Alfred Akirov - Net Worth and Insider Trading
Alfred Akirov Net Worth
The estimated net worth of Alfred Akirov is at least $570,184 dollars as of 2024-11-08. Alfred Akirov is the Director of Protalix BioTherapeutics Inc and owns about 491,538 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $570,184. Details can be seen in Alfred Akirov's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alfred Akirov has not made any transactions after 2013-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alfred Akirov
Alfred Akirov Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alfred Akirov owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Alfred Akirov’s form 4 insider trades.
Insider Ownership Summary of Alfred Akirov
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2013-08-15 | director |
Alfred Akirov Latest Holdings Summary
Alfred Akirov currently owns a total of 1 stock. Alfred Akirov owns 491,538 shares of Protalix BioTherapeutics Inc (PLX) as of August 15, 2013, with a value of $570,184.
Latest Holdings of Alfred Akirov
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2013-08-15 | 491,538 | 1.16 | 570,184 |
Holding Weightings of Alfred Akirov
Alfred Akirov Form 4 Trading Tracker
According to the SEC Form 4 filings, Alfred Akirov has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the sale of 11,233 shares on August 15, 2013, which brought Alfred Akirov around $567,266.
Insider Trading History of Alfred Akirov
- 1
Alfred Akirov Trading Performance
Alfred Akirov Ownership Network
Ownership Network List of Alfred Akirov
Ownership Network Relation of Alfred Akirov
Alfred Akirov Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Alfred Akirov is the director of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Alfred Akirov made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 64,516 shares made by Dror Bashan ,
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 64,516 shares were bought by its insiders, resulting in a net purchase of 64,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Alfred Akirov Mailing Address
Above is the net worth, insider trading, and ownership report for Alfred Akirov. You might contact Alfred Akirov via mailing address: Alrov Tower, 46 Rothschild Blvd, Tel Aviv L3 66883.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
